Eric Sievers, MD [clinicaltrials_resource:3613879c76a4064f7ffbfe7eb6505206]
Detection of Residual Disease in Children Receiving Therapy for Acute Myeloid Leukemia or Myelodysplastic Syndrome [clinicaltrials:NCT00003790]Gemtuzumab Ozogamicin, Fludarabine, and Total-body Irradiation Followed by Peripheral Stem Cell or Bone Marrow Transplantation in Treating Patients With Advanced Acute Myeloid Leukemia or Myelodysplastic Syndrome [clinicaltrials:NCT00008151]
overall official [clinicaltrials_vocabulary:overall-official]
Eric Sievers, MD [clinicaltrials_resource:3613879c76a4064f7ffbfe7eb6505206]
Bio2RDF identifier
3613879c76a4064f7ffbfe7eb6505206
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:3613879c76a4064f7ffbfe7eb6505206
affiliation [clinicaltrials_vocabulary:affiliation]
last name [clinicaltrials_vocabulary:last-name]
Eric Sievers, MD
role [clinicaltrials_vocabulary:role]
Study Chair
identifier
clinicaltrials_resource:3613879c76a4064f7ffbfe7eb6505206
title
Eric Sievers, MD
@en
type
label
Eric Sievers, MD [clinicaltrials_resource:3613879c76a4064f7ffbfe7eb6505206]
@en